Literature DB >> 26633946

Finding the Lesser of Two Evils: Treating Refractory Status Epilepticus.

Lawrence J Hirsch.   

Abstract

Entities:  

Year:  2015        PMID： 26633946      PMCID： PMC4657779          DOI： 10.5698/1535-7511-15.6.313

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

1.  High-dose midazolam infusion for refractory status epilepticus.

Authors:  Andres Fernandez; Hector Lantigua; Christine Lesch; Belinda Shao; Brandon Foreman; J Michael Schmidt; Lawrence J Hirsch; Stephan A Mayer; Jan Claassen
Journal:  Neurology       Date:  2013-12-20       Impact factor: 9.910

2.  Clinical outcomes following prolonged refractory status epilepticus (PRSE).

Authors:  R D Kilbride; A S Reynolds; J P Szaflarski; L J Hirsch
Journal:  Neurocrit Care       Date:  2013-06       Impact factor: 3.210

3.  Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.

Authors:  Raoul Sutter; Stephan Marsch; Peter Fuhr; Peter W Kaplan; Stephan Rüegg
Journal:  Neurology       Date:  2013-12-06       Impact factor: 9.910

4.  Seizure burden is independently associated with short term outcome in critically ill children.

Authors:  Eric T Payne; Xiu Yan Zhao; Helena Frndova; Kristin McBain; Rohit Sharma; James S Hutchison; Cecil D Hahn
Journal:  Brain       Date:  2014-03-04       Impact factor: 13.501

Review 5.  Electrographic seizures and status epilepticus in critically ill children and neonates with encephalopathy.

Authors:  Nicholas S Abend; Courtney J Wusthoff; Ethan M Goldberg; Dennis J Dlugos
Journal:  Lancet Neurol       Date:  2013-12       Impact factor: 44.182
  5 in total
  5 in total

1.  Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients.

Authors:  Chloe E Hill; Leah J Blank; Dylan Thibault; Kathryn A Davis; Nabila Dahodwala; Brian Litt; Allison W Willis
Journal:  Neurology       Date:  2018-11-30       Impact factor: 9.910

2.  Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures.

Authors:  Aatif M Husain; Jong W Lee; Bradley J Kolls; Lawrence J Hirsch; Jonathan J Halford; Puneet K Gupta; Yafa Minazad; Jennifer M Jones; Suzette M LaRoche; Susan T Herman; Christa B Swisher; Saurabh R Sinha; Adriana Palade; Keith E Dombrowski; William B Gallentine; Cecil D Hahn; Elizabeth E Gerard; Manjushri Bhapkar; Yuliya Lokhnygina; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-06       Impact factor: 10.422

Review 3.  Pharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus.

Authors:  Pablo Bravo; Aparna Vaddiparti; Lawrence J Hirsch
Journal:  Drugs       Date:  2021-04-08       Impact factor: 9.546

4.  Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study.

Authors:  Vincent Alvarez; Jong Woo Lee; M Brandon Westover; Frank W Drislane; Jan Novy; Mohamed Faouzi; Nicola A Marchi; Barbara A Dworetzky; Andrea O Rossetti
Journal:  Neurology       Date:  2016-09-24       Impact factor: 9.910

5.  Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.

Authors:  Dominik Madžar; Caroline Reindl; Antje Giede-Jeppe; Tobias Bobinger; Maximilian I Sprügel; Ruben U Knappe; Hajo M Hamer; Hagen B Huttner
Journal:  Crit Care       Date:  2018-11-21       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.